These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32970524)

  • 1. Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer.
    Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath LG
    JCO Oncol Pract; 2021 Feb; 17(2):e204-e216. PubMed ID: 32970524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
    JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
    Cheng HH; Sokolova AO; Gulati R; Bowen D; Knerr SA; Klemfuss N; Grivas P; Hsieh A; Lee JK; Schweizer MT; Yezefski T; Zhou A; Yu EY; Nelson PS; Montgomery B
    JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
    Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Prostate Cancer: Effects of Genetic Testing on Care.
    Connors LM
    Clin J Oncol Nurs; 2019 Feb; 23(1):32-35. PubMed ID: 30681994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
    J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
    Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
    BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.
    Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J
    Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline pathogenic variants in unselected Korean men with prostate cancer.
    So MK; Ahn HK; Huh J; Kim KH
    Investig Clin Urol; 2022 May; 63(3):294-300. PubMed ID: 35534218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited DNA-repair gene mutations in African American men with prostate cancer.
    Sartor O; Yang S; Ledet E; Moses M; Nicolosi P
    Oncotarget; 2020 Jan; 11(4):440-442. PubMed ID: 32064047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline genetics of prostate cancer.
    Khan HM; Cheng HH
    Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S3-S12. PubMed ID: 35657157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Australian mainstream genetic testing program: Clinicians views about current and future practices.
    Young AL; Ip E; Scheinberg T; Harrison M; Beale P; Goodwin A
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):119-127. PubMed ID: 37985938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.
    McDonald HG; Kennedy A; Solomon AL; Williams CM; Reagan AM; Cassim E; Harper M; Burke E; Armstrong T; Gosky M; Cavnar M; Pandalai PK; Barry-Hundeyin M; Patel R; Nutalapati S; Moss J; Hull PC; Kolesar J; Pickarski JC; Kim J
    Ann Surg Oncol; 2024 Nov; 31(12):7705-7712. PubMed ID: 39133448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort.
    Song SH; Kim HM; Jung YJ; Kook HR; Jeon S; Bhak J; Kim JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
    World J Mens Health; 2023 Oct; 41(4):960-968. PubMed ID: 37118955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a universal germline screening program in a community urology practice.
    Mendhiratta N; Hauver H; Hatton W; Ostrusky A; Sathe DS; Gurram S; Rice P; Chalfin H
    Clin Genet; 2024 Sep; 106(3):277-283. PubMed ID: 38711401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
    Abusamra SM; Solorzano MA; Luke M; Quarles J; Jacobs MF; Das S; Kasputis A; Okoth LA; Patel M; Seymore M; Caram MEV; Dunn RL; Merajver SD; Stoffel EM; Reichert ZR; Morgan TM
    J Urol; 2022 Nov; 208(5):1007-1017. PubMed ID: 35930793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
    Freedland SJ; Aronson WJ
    Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.